rediff.com
Rediff Moneywiz
Home
Market News
My Portfolio
My Watchlist
Trends
Hi Guest
Feedback
Investment Tool
Forex
Indices
Sectors
Mutual Funds
Gainers
Losers
Import Portfolio
All Pages
e.g. Tata motors, Reliance MF, 500570
Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Download
< Back
14 Oct 2024
Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease.
View all announcements for Zydus Lifesciences Ltd
Source: BSE India